Navigation Links
R-Squared Forms Strategic Relationship with IMS Health

PRINCETON, N.J., Feb. 18 /PRNewswire/ -- R-Squared, an industry leader in evidence-based compliance solutions, today announced a strategic alliance with IMS Health Inc., to help pharmaceutical and medical device manufacturers comply with the growing body of state transparency and marketing disclosure laws, known as "aggregate spend" reporting laws. As part of the alliance, R-Squared's state-of-the-art SpendTracker® compliance application platform will be deployed to support IMS's new Aggregate Spend Compliance Services.

SpendTracker represents the culmination of R-Squared's years of legal and in-the-trenches compliance experience plus the most flexible technology purposefully designed for aggregate spend compliance. The combination of IMS's rich data sets and R-Squared's patent-pending dynamic linking yields almost limitless analytical and operational uses of the data. Through the alliance, IMS will provide implementation, hosting, analytics, world-class master data management, and the full array of support services for SpendTracker implementations and aggregate spend compliance, as appropriate for a client's unique needs.

"IMS evaluated a number of companies, ultimately selecting R-Squared to support our aggregate spend solution because of their strong technology platform," said Don Otterbein, general manager, Business Transformation Services, IMS. "Through this alliance, we will be able to leverage our industry-leading reference data, advisory services, and data management capabilities to deliver an accurate view of spend associated with the healthcare professional."

"R-Squared is committed to working with best-in-class organizations to help resolve critical compliance and operational challenges," said Michael Bell, President and Chief Executive Officer of R-Squared. "By aligning with a genuine industry leader, we bring together R-Squared's strength in creating easy-to-use and configurable compliance software with IMS's unique combination of global information, analytics, and consulting services to offer unparalleled compliance services for the life sciences industry. This is iron-clad compliance plus business intelligence, and is truly a unique and highly valuable offering."

About R-Squared

R-Squared Services & Solutions, Inc. is a leading developer of evidence-based compliance and data management solutions for the health care and life sciences industries. Through patent-pending extensions to Microsoft SharePoint, R-Squared has developed configurable, cost-effective solutions that integrate seamlessly with existing workflows and software systems, prevent costly errors from happening, and maintain evidence of compliance. To learn more, please visit: .

SOURCE R-Squared



SOURCE R-Squared
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS
2. VisEn Acquires Key Fluorescence Agent Intellectual Property Portfolio and Technology Platforms From Bayer Schering Pharma
3. JDRF Forms Partnership With Animas to Develop First-Generation Automated System for Managing Type 1 Diabetes
4. Zassi Medical Evolutions Spins out Electrical Stimulation Technology for Gastrointestinal Continence Control and Forms New Company with Technology Investment Firm
5. Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group
6. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
7. Rules-Based Medicine Forms Biomarker Alliance With Covance Inc.
8. CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms
9. Obama Healthcare Reforms Fall Short, but Closes the Donut Hole
10. Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
11. American University of Beirut Medical Team Successfully Performs First Artificial Heart Implant in Lebanon
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... --> adds "Global Repaglinide ... "Investigation Report on China Repaglinide Market, ... forecasts data and information to its ... . --> ...
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology:
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... a real-time eReferral system for diagnostic imaging in the Waterloo region. Using the ... and Nuclear Medicine tests directly from their electronic medical record (EMR) without the ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug Delivery ... to integrate dose form selection in early phase drug development. The first of ... and bringing together the UK’s emerging life sciences companies, corporate partners, and investors, ...
(Date:11/26/2015)... , ... November 26, 2015 , ... PRMA Plastic Surgery ... 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , “What ... up every day excited to rebuild lives and it’s an honor to have served ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer ... classically-influenced trailer titles work with any font, giving users limitless opportunities to stylize ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of ... server to improve system efficiency and reliability. , The new Q-Suite 6 platform is ... the system avoids locking itself into a specific piece of software for many key ...
Breaking Medicine News(10 mins):